Pagnossa, J.P.; Rodrigues, S.d.O.; Oliveira, G.F.d.; Adnan, M.; Aljaid, M.S.; Assis, I.B.d.; Lima, A.S.G.; Patel, M.; Ogaly, H.A.; Batiha, G.E.-S.
COVID-19 in a Pre-Omicron Era: A Cross-Sectional Immuno-Epidemical and Genomic Evaluation. Vaccines 2023, 11, 272.
https://doi.org/10.3390/vaccines11020272
AMA Style
Pagnossa JP, Rodrigues SdO, Oliveira GFd, Adnan M, Aljaid MS, Assis IBd, Lima ASG, Patel M, Ogaly HA, Batiha GE-S.
COVID-19 in a Pre-Omicron Era: A Cross-Sectional Immuno-Epidemical and Genomic Evaluation. Vaccines. 2023; 11(2):272.
https://doi.org/10.3390/vaccines11020272
Chicago/Turabian Style
Pagnossa, Jorge Pamplona, Sarah de Oliveira Rodrigues, Gabriel Ferrari de Oliveira, Mohd Adnan, Maryam Saud Aljaid, Isabela Bacelar de Assis, Alex Sandro Gomes Lima, Mitesh Patel, Hanan A. Ogaly, and Gaber El-Saber Batiha.
2023. "COVID-19 in a Pre-Omicron Era: A Cross-Sectional Immuno-Epidemical and Genomic Evaluation" Vaccines 11, no. 2: 272.
https://doi.org/10.3390/vaccines11020272
APA Style
Pagnossa, J. P., Rodrigues, S. d. O., Oliveira, G. F. d., Adnan, M., Aljaid, M. S., Assis, I. B. d., Lima, A. S. G., Patel, M., Ogaly, H. A., & Batiha, G. E.-S.
(2023). COVID-19 in a Pre-Omicron Era: A Cross-Sectional Immuno-Epidemical and Genomic Evaluation. Vaccines, 11(2), 272.
https://doi.org/10.3390/vaccines11020272